fashion -WSS

fashion

author：fashion 2025-10-02 18:48:32 - browse：1722

Eli Lilly headquarters — Kristoffer Tripplaar/AP

SAN DIEGO – An experimental pill from Eli Lilly led to 14.7% weight loss on the highest dose in a 36-week trial, heating up the growing competition among drugmakers to develop an effective oral obesity therapy.

The mid-stage results for orforglipron match the estimates of 14-15% weight loss that Lilly gave in an investor call late last year. The full results, published Friday in the New England Journal of Medicine, were presented here to a packed conference room at the American Diabetes Association conference.

By the end of trial, the authors said, participants’ weight loss had not plateaued, suggesting potential for even greater weight loss over a longer treatment period.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： NIH documents show early flaws of $1.6 billion long Covid program

WSS

ASCO 2024: 'Reassuring' Corbus data on ADC bladder cancer drug

Stem cell biologist probes earliest stages of human development

For one rare type of lung cancer, Pfizer pill reduces progression by 81%

ASCO24: AstraZeneca won cancer’s big meeting. Can it fulfill its $80B ambition?

Immune cells and nerve overgrowth may explain recurring UTI pain

First over

hotspot

fashion

focus

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Biden's 'march

Trump demands the U.S. pay no more for drugs than other countries … again

ASCO: AstraZeneca says CAR

Affirmative action in medical school literally saved lives

Ionis drug prevents swelling attacks due to hereditary angioedema

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

For one rare type of lung cancer, Pfizer pill reduces progression by 81%

Drug repurposing or repositioning? The language matters

Florida health officials providing scant details on measles cases

Wikipedia

For one rare type of lung cancer, Pfizer pill reduces progression by 81%

How to increase colonoscopy rates? Looks like an AI can help

Readout Newsletter: The latest on Novo Nordisk, Alnylam, Apogee

Readout Newsletter: The latest on Novo Nordisk, Alnylam, Apogee

With trial win, GSK could get blood cancer drug back on market

ASCO: AstraZeneca says CAR

focus

leisure time

Wikipedia

Wikipedia